V. Thybaud - Concepedia

Author

V. Thybaud

Sanofi (France)

Also Known As

V. Thybaud, V�ronique Thybaud

Publications

599

Citations

H-Index

Concepts

All Affiliations

Sanofi (France)Food Safety and Inspection Service Health and Environmental Sciences Institute United States Military Academy Dow Chemical (United States)

About

V. Thybaud is an author at Sanofi (France) specializing in medicine, toxicology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	357
2	Public Health	2	2	275
3	Engineering	1	1	47
4	Allergy	1	1	20
5	Biostatistics	1	1	144

V. Thybaud

Publications

590

Citations

H-Index

Page 1

	Year	Citations
Derivation of point of departure (PoD) estimates in genetic toxicology studies and their potential applications in risk assessment George E. Johnson, Lya G. Soeteman‐Hernández, B. Bhaskar Gollapudi, Environmental and Molecular Mutagenesis GeneticsEcological Risk AssessmentGenetic EpidemiologyMethyl MethanesulfonatePotential Applications	2014	144
Quantitative approaches for assessing dose–response relationships in genetic toxicology studies B. Bhaskar Gollapudi, George E. Johnson, Lya G. Soeteman‐Hernández, Environmental and Molecular Mutagenesis	2012	143
Strategy for genotoxicity testing: Hazard identification and risk assessment in relation to in vitro testing V. Thybaud, Marilyn J. Aardema, Julie Clements, Mutation Research/Genetic Toxicology and Environmental Mutagenesis Hazard IdentificationVitro TestingToxicology TestingToxicologyEnvironmental Toxicology	2006	131
Standardized cell sources and recommendations for good cell culture practices in genotoxicity testing Elisabeth Lorge, Martha M. Moore, Julie Clements, Mutation Research/Genetic Toxicology and Environmental Mutagenesis	2016	90
Potential impurities in drug substances: Compound-specific toxicology limits for 20 synthetic reagents and by-products, and a class-specific toxicology limit for alkyl bromides Joel P. Bercu, Sheila M. Galloway, Patricia Parris, Regulatory Toxicology and Pharmacology Chemical SafetyPotential ImpuritiesEngineeringMedicineDrug Purity	2018	47
Validation of the <i>in vivo</i> CD1 mouse splenocyte micronucleus test Véronique Benning, Daniel Brault, Catherine Duvinage, Mutagenesis ImmunotoxicologyImmunologyPathologyVivo Micronucleus TestAcridine Orange	1994	20
Optimum associations of tester strains for maximum detection of mutagenic compounds in the Ames test D Bonneau, V. Thybaud, C. Melción, Mutation Research/Environmental Mutagenesis and Related Subjects Tester StrainsMutation-based TestingGeneticsBioanalysisForensic Toxicology	1991	15

Page 1